Management of Post-Viral Cough in Asthmatic Patients

Diagnosis and Clinical Presentation

The American College of Chest Physicians suggests that a subacute post-infectious cough, lasting more than 3 days but less than 8 weeks, following a viral upper respiratory infection, is a common presentation in patients with asthma history 1, 3
The presence of expiratory wheeze indicates bronchial hyperresponsiveness consistent with asthma exacerbation, as noted by the Journal of Allergy and Clinical Immunology 4
A 9-day timeline with initial viral symptoms followed by progressive cough development fits the typical post-viral pattern, according to the Chest journal 1, 3

The Journal of Allergy and Clinical Immunology recommends initiating inhaled corticosteroid (ICS) therapy immediately in patients with asthma history and current evidence of bronchial hyperresponsiveness (wheeze) 5, 4
Fluticasone propionate 200 mcg once daily via metered-dose inhaler is a recommended regimen, as suggested by the Journal of Allergy and Clinical Immunology 5, 4
The American Academy of Pediatrics and the American College of Obstetricians and Gynecologists agree that ICS have minimal systemic absorption and are considered appropriate for lactating women 2

The Chest journal suggests that a combination of first-generation antihistamine and decongestant has been shown to decrease cough severity and hasten resolution in post-viral cough 1, 3
Chlorpheniramine 4 mg + pseudoephedrine 60 mg every 6 hours for 7-10 days is a specific recommendation, as noted by the Chest journal 1
Non-pharmacologic measures such as honey, warm fluids, or simple linctuses provide symptomatic relief through central modulation of the cough reflex, according to the Praxis Medical Insights 3
Naproxen 250-500 mg twice daily has been shown to favorably affect post-viral cough, as suggested by the Chest journal and the Praxis Medical Insights 1, 3

The American Academy of Pediatrics recommends continuing breastfeeding without interruption, as breast milk provides protective antibodies that actively protect the infant against respiratory infections 2
Infants who are not breastfed have almost threefold greater risk of hospitalization for lower respiratory tract disease, as noted by the Praxis Medical Insights 2
Practice strict hand hygiene before every feeding to minimize transmission, as suggested by the Pediatrics journal and the Praxis Medical Insights 2, 7

Reassess in 2 weeks, as expected improvement with ICS therapy within 1-2 weeks, according to the Journal of Allergy and Clinical Immunology 5
If cough persists beyond 8 weeks, it meets criteria for chronic cough and requires systematic evaluation for UACS, asthma, and GERD, as noted by the Chest journal and the Praxis Medical Insights 1, 6
Development of fever, hemoptysis, weight loss, or night sweats requires immediate re-evaluation, as suggested by the Praxis Medical Insights and the Journal of Allergy and Clinical Immunology 3, 8